Ocuphire Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ocuphire Pharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 52% to $19,049,000. Profit margin reached -52%. Total operating expenses were $29,606,000.

Profit Margin

Ocuphire Pharma, Inc. (NASDAQ:OCUP): Profit margin
2014 0 -18.52M
2015 0 -14.38M
2016 0 -9.30M
2017 0 -25.29M
2018 0 -14.36M
2019 0 -7.51M
2020 0 -31.47M
2021 589K -56.53M -9598.3%
2022 39.85M 17.88M 44.89%
2023 19.04M -9.98M -52.42%

OCUP Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
19.04M39.85M589K0000000
Cost of revenue
6K4K4K8K3K042.35K027.49K0
Gross profit
19.04M39.84M585K-8K-3K0-42.35K0-27.49K0
Operating exp.
Research and development
17.65M14.35M15.17M6.64M2.37M13.10M10.71M10.08M12.14M7.01M
Selling and marketing
-6K00000-42.35K0-27.49K0
Total operating expenses
29.60M21.62M23.29M9.46M4.19M20.53M17.31M16.41M18.23M13.26M
Operating income
-10.56M18.22M-22.70M-19.96M-4.19M-20.53M-17.35M-16.41M-18.26M-13.26M
Other income (expenses), net
589K-23K-33.98M-4.65M-1.97M6.16M-7.93M7.10M3.87M-5.25M
Income before tax
-9.97M18.20M-56.69M-24.62M-6.16M-14.36M-25.29M-9.30M-14.38M-18.52M
Income tax expense
12K315K-159K6.85M1.34M02020
Net income
-9.98M17.88M-56.53M-31.47M-7.51M-14.36M-25.29M-9.30M-14.38M-18.52M
Earnings per share
Basic EPS
-0.460.9-3.81-6.75-10.56-0.44-44.33-0.04-37.86-0.11
Diluted EPS
-0.460.87-3.81-6.75-10.56-0.44-44.33-0.04-37.86-0.11
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source